Compans Marie-Caroline
University of Vienna, Wittgenstein Centre for Demography and Global Human Capital (IIASA, OeAW, University of Vienna).
Popul Dev Rev. 2024 Dec;50(4):1319-1351. doi: 10.1111/padr.12658. Epub 2024 Sep 30.
This paper focuses on age restrictions on access to infertility treatments and eligibility for their public reimbursement, exploring their relevancy in contexts of rising late birth rates (40+). I explore how age-based reimbursement policies for in vitro fertilization treatments have responded to these fertility trends in 27 high-income countries and in which regulatory frameworks for medically assisted reproduction (MAR) very late births (45+) have particularly increased. First, I show that while age limits for treatment reimbursement are well aligned with the prevalence of late fertility in some national contexts, in most countries, strict age restrictions are lagging behind the rise in late births. In others, pronatalist policies have prompted permissive age criteria or law revisions, anticipating or adapting to rising trends in late births. Second, the rise in very late births has been limited in some contexts with strict age-based rules. However, the analysis suggests that the impact of MAR on very late births may also be influenced by contextual factors other than regulations.
本文聚焦于获取不孕治疗的年龄限制及其公共报销资格,探讨在晚育率上升(40岁及以上)的背景下这些限制的相关性。我研究了27个高收入国家中基于年龄的体外受精治疗报销政策如何应对这些生育趋势,以及在哪些医学辅助生殖(MAR)监管框架下,极高龄生育(45岁及以上)的情况尤其增多。首先,我表明,虽然治疗报销的年龄限制在某些国家背景下与晚育的普遍程度相契合,但在大多数国家,严格的年龄限制滞后于晚育率的上升。在其他国家,鼓励生育的政策促使了宽松的年龄标准或法律修订,以预期或适应晚育率上升的趋势。其次,在一些有严格年龄规定的情况下,极高龄生育的增长受到了限制。然而,分析表明,医学辅助生殖对极高龄生育的影响也可能受到法规以外的背景因素的影响。